Supplemental Evidence and Data Request on Impact of Healthcare Worker Safety and Wellness: A Systematic Review, 103828-103830 [2024-30259]
Download as PDF
103828
Federal Register / Vol. 89, No. 244 / Thursday, December 19, 2024 / Notices
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments received are subject to
public disclosure. In general, comments
received will be made available without
change and will not be modified to
remove personal or business
information including confidential,
contact, or other identifying
information. Comments should not
include any information such as
confidential information that would not
be appropriate for public disclosure.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than January 21, 2025.
A. Federal Reserve Bank of Boston
(Prabal Chakrabarti, Senior Vice
President) 600 Atlantic Avenue, Boston,
Massachusetts 02210–2204. Comments
can also be sent electronically to
BOS.SRC.Applications.Comments@
bos.frb.org:
1. Winchester Bancorp, MHC,
Winchester, Massachusetts; to become a
bank holding company by acquiring at
least 50.1 percent of the voting shares of
Winchester Bancorp, Inc., a mid-tier
holding company, through a mutual
holding company reorganization and
minority stock issuance, and thereby
indirectly acquiring voting shares of
Winchester Savings Bank, both of
Winchester, Massachusetts.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Associate Secretary of the Board.
[FR Doc. 2024–30299 Filed 12–18–24; 8:45 am]
BILLING CODE 6210–01–P
FEDERAL RESERVE SYSTEM
Michele Taylor Fennell,
Associate Secretary of the Board.
lotter on DSK11XQN23PROD with NOTICES1
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
[FR Doc. 2024–30298 Filed 12–18–24; 8:45 am]
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
VerDate Sep<11>2014
18:08 Dec 18, 2024
Jkt 265001
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments received are subject to
public disclosure. In general, comments
received will be made available without
change and will not be modified to
remove personal or business
information including confidential,
contact, or other identifying
information. Comments should not
include any information such as
confidential information that would not
be appropriate for public disclosure.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than January 3, 2025.
A. Federal Reserve Bank of Richmond
(Brent B. Hassell, Assistant Vice
President) P.O. Box 27622, Richmond,
Virginia 23261. Comments can also be
sent electronically to
Comments.applications@rich.frb.org:
1. The Craig G. Phillips Revocable
Trust, Craig G. Phillips, as trustee, both
of Buckhannon, West Virginia; to
acquire voting shares of Freedom
Bancshares, Inc., and thereby indirectly
acquire voting shares of Freedom Bank,
Inc., both of Belington, West Virginia.
Board of Governors of the Federal
Reserve System.
BILLING CODE P
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Supplemental Evidence and Data
Request on Impact of Healthcare
Worker Safety and Wellness: A
Systematic Review
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for supplemental
evidence and data submission.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
the public. Scientific information is
being solicited to inform our review on
Impact of Healthcare Worker Safety and
Wellness: A Systematic Review, which
is currently being conducted by the
AHRQ’s Evidence-based Practice
Centers (EPC) Program. Access to
published and unpublished pertinent
scientific information will improve the
quality of this review.
DATES: Submission Deadline on or
before January 21, 2025.
ADDRESSES:
Email submissions: epc@
ahrq.hhs.gov.
Print submissions:
Mailing Address: Center for Evidence
and Practice Improvement, Agency for
Healthcare Research and Quality,
ATTN: EPC SEADs Coordinator, 5600
Fishers Lane, Mail Stop 06E53A,
Rockville, MD 20857
Shipping Address (FedEx, UPS, etc.):
Center for Evidence and Practice
Improvement, Agency for Healthcare
Research and Quality, ATTN: EPC
SEADs Coordinator, 5600 Fishers
Lane, Mail Stop 06E77D, Rockville,
MD 20857
FOR FURTHER INFORMATION CONTACT:
Kelly Carper, eelephone: 301–427–1656
or email: epc@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION: The
Agency for Healthcare Research and
Quality has commissioned the
Evidence-based Practice Centers (EPC)
Program to complete a review of the
evidence for Impact of Healthcare
Worker Safety and Wellness: A
Systematic Review. AHRQ is conducting
this review pursuant to section 902 of
the Public Health Service Act, 42 U.S.C.
299a.
The EPC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
SUMMARY:
E:\FR\FM\19DEN1.SGM
19DEN1
Federal Register / Vol. 89, No. 244 / Thursday, December 19, 2024 / Notices
literature by requesting information
from the public (e.g., details of studies
conducted). We are looking for studies
that report on Impact of Healthcare
Worker Safety and Wellness: A
Systematic Review. The entire research
protocol is available online at: https://
effectivehealthcare.ahrq.gov/products/
worker-safety-wellness/protocol.
This is to notify the public that the
EPC Program would find the following
information on Impact of Healthcare
Worker Safety and Wellness: A
Systematic Review helpful:
D A list of completed studies that
your organization has sponsored for this
topic. In the list, please indicate
whether results are available on
ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
D For completed studies that do not
have results on ClinicalTrials.gov, a
summary, including the following
elements, if relevant: study number,
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, primary and secondary
outcomes, baseline characteristics,
number of patients screened/eligible/
enrolled/lost to follow-up/withdrawn/
analyzed, effectiveness/efficacy, and
safety results.
D A list of ongoing studies that your
organization has sponsored for this
topic. In the list, please provide the
ClinicalTrials.gov trial number or, if the
trial is not registered, the protocol for
the study including, if relevant, a study
number, the study period, design,
methodology, indication and diagnosis,
proper use instructions, inclusion and
exclusion criteria, and primary and
secondary outcomes.
D Description of whether the above
studies constitute ALL Phase II and
above clinical trials sponsored by your
organization for this topic and an index
outlining the relevant information in
each submitted file.
Your contribution is very beneficial to
the Program. Materials submitted must
be publicly available or able to be made
public. Materials that are considered
confidential; marketing materials; study
types not included in the review; or
information on topics not included in
the review cannot be used by the EPC
Program. This is a voluntary request for
information, and all costs for complying
with this request must be borne by the
submitter.
103829
The draft of this review will be posted
on AHRQ’s EPC Program website and
available for public comment for a
period of 4 weeks. If you would like to
be notified when the draft is posted,
please sign up for the email list at:
https://effectivehealthcare.ahrq.gov/
email-updates.
The review will answer the following
questions. This information is provided
as background. AHRQ is not requesting
that the public provide answers to these
questions.
Contextual Question: What are the
manifestations of impaired safety and
wellbeing of HCWs, such as burnout,
moral injury, emotional exhaustion,
staff turnover, and physical injuries?
Key Questions (KQ)
KQ 1: What are the associations
between healthcare delivery conditions
and HCW burnout?
KQ 2: What are the associations
between HCW burnout and outcomes
for patients, HCW families, healthcare
delivery organizations, and society?
KQ 3: What are the effectiveness and
harms of system-level interventions
targeting HCW burnout?
PECOTS (POPULATIONS, EXPOSURES, COMPARATORS, OUTCOMES, TIMING AND SETTING) ELIGIBILITY CRITERIA FOR ALL
KEY QUESTIONS
lotter on DSK11XQN23PROD with NOTICES1
Element
Key Question 1
Key Question 2
Key Question 3
Population .........
HCWs at all organizational levels (e.g., those who provide direct patient care, support personnel, managers, executives) Examples:
• Physicians.
• Nurses: registered nurses and advanced practice nurses.
• Pharmacists.
• Allied healthcare professionals (e.g., respiratory therapists, physical therapists, social workers, emergency medical technicians).
• Support personnel (e.g., environmental services).
• Managers.
• Executives.
Exposure ...........
All healthcare delivery conditions associated
with the included studies will be recorded as
exposures, including
• Societal conditions, including federal
and state laws like nurse staffing laws,
policies like pandemic restrictions and
credentialing, and unemployment,
healthcare utilization, and unionization
rates.
• Organizational factors such as payment
model, level of care, precarious and unstable scheduling, safety culture.
• Job and task-specific factors, such as
occupational class, shift characteristics,
working hours, occupational stressors,
support, teamwork, and workplace hazards Individual factors, such as age and
experience.
HCW burnout, including instruments such as:
• Maslach Burnout Inventory
• Oldenburg Burnout Inventory
• Copenhagen Burnout Inventory
• Two-Item Maslach Burnout Inventory
• Physician Worklife Study Single Item
Question
• ProQOL Burnout scale
• Institute for Professional Worklife Mini Z
Survey
System-level programs: interventions that intend to reduce or prevent HCW burnout
through the elimination or substitution of occupational hazards.
Exclude: interventions that enable the occupational hazard to remain in place (engineering, administrative controls) or increase the
individual capacity to cope with the hazard
(PPE, resilience training).
Comparator .......
Other healthcare delivery condition.
Other levels of HCW burnout.
• Other intervention.
• No intervention.
VerDate Sep<11>2014
18:44 Dec 18, 2024
Jkt 265001
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
E:\FR\FM\19DEN1.SGM
19DEN1
103830
Federal Register / Vol. 89, No. 244 / Thursday, December 19, 2024 / Notices
PECOTS (POPULATIONS, EXPOSURES, COMPARATORS, OUTCOMES, TIMING AND SETTING) ELIGIBILITY CRITERIA FOR ALL
KEY QUESTIONS—Continued
Element
Key Question 1
Key Question 2
Key Question 3
Outcomes ..........
HCW burnout, including instruments such as:
• Maslach Burnout Inventory
• Oldenburg Burnout Inventory
• Copenhagen Burnout Inventory
• Two-Item Maslach Burnout Inventory
• Physician Worklife Study Single Item
Question
• Professional Quality of Life (ProQOL)
Burnout scale
• Institute for Professional Worklife Mini Z
Survey
• HCW family outcomes, such as:
Æ Marital/relationship stress measured by
a partner
Æ Divorce/separation rates
• Patient outcomes, such as:
Æ Safety
Æ Satisfaction
Æ Adverse events
Æ Mortality
• Healthcare organization outcomes, such as:
Æ Productivity (including presenteeism,
absenteeism, work-related injuries and
illnesses)
Æ Staff turnover (including due to retirement, leaving the profession, mortality,
or suicide)
• Societal outcomes, such as:
Æ Workforce shortages
HCW burnout, including instruments such as:
• Maslach Burnout Inventory.
• Oldenburg Burnout Inventory.
• Copenhagen Burnout Inventory.
• Two-Item Maslach Burnout Inventory.
• Physician Worklife Study Single Item
Question.
• ProQOL Burnout scale.
• Institute for Professional Worklife Mini Z
Survey.
Mediating Factors.
• Individual factors such as stress, satisfaction, wellbeing, engagement, sleep quality, suicidal ideation, depression, anxiety, meaningful work,
mattering, moral distress or injury, workplace injury or illness.
Modifying Factors.
Æ
Æ
Æ
Æ
Æ
Æ
Æ
Æ
Æ
Study Designs ...
• Cross-sectional studies.
• Cohort studies.
Demographic characteristics: (e.g., age, sex, race, ethnicity).
Occupational title (e.g., physician, nurse, allied health professional, other).
Educational attainment (e.g., high school, some college, college degree, graduate degree).
Experience (e.g., number of years employed).
Income (e.g., household income, socioeconomic status).
Time (e.g., year of outcome ascertainment, or binned by pre-, concurrent and post-pandemic).
Shift characteristics: (e.g., timing, duration, knowledge of shift, mandatory overtime).
Job tasks (e.g., patient-facing vs. non-patient-facing, physical demands as high, moderate, low).
Geographic location (e.g., U.S. census region, urban vs. suburban vs. rural).
• Randomized controlled trials.
• Non-randomized controlled trials.
• Observational cohort studies with a comparison group.
• Pre-post studies (with adjustment for confounders).
Timing ...............
Published since 2014.
Settings .............
All U.S. healthcare delivery settings where HCWs work (e.g., ambulatory, prehospital, emergency, various inpatient services, post-acute or skilled
nursing/long-term care, including medical, surgical, and mental health care settings).
Abbreviations: HCW = healthcare worker; PPE = personal protective equipment, ProQOL = Professional Quality of Life.
Dated: December 12, 2024.
Marquita Cullom,
Associate Director.
[FR Doc. 2024–30259 Filed 12–18–24; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
lotter on DSK11XQN23PROD with NOTICES1
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention, pursuant to Public Law 92–
463. The grant applications and the
discussions could disclose confidential
VerDate Sep<11>2014
18:08 Dec 18, 2024
Jkt 265001
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel;
(SEP)—RFA–OH–25–002, Panel A,
Occupational Safety and Health
Education and Research Centers (ERC).
Dates: February 24–25, 2025.
Times: 11:00 a.m.–5:00 p.m., EST.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Dan
Hartley, Ed.D., Scientific Review
Officer, Office of Extramural Programs,
National Institute for Occupational
Safety and Health, Centers for Disease
Control and Prevention, 1095
Willowdale Road, Morgantown, West
Virginia 26505. Telephone: (304) 285–
5812; Email: DHartley@cdc.gov.
PO 00000
Frm 00067
Fmt 4703
Sfmt 9990
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–30238 Filed 12–18–24; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\19DEN1.SGM
19DEN1
Agencies
[Federal Register Volume 89, Number 244 (Thursday, December 19, 2024)]
[Notices]
[Pages 103828-103830]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30259]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Supplemental Evidence and Data Request on Impact of Healthcare
Worker Safety and Wellness: A Systematic Review
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Request for supplemental evidence and data submission.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) is
seeking scientific information submissions from the public. Scientific
information is being solicited to inform our review on Impact of
Healthcare Worker Safety and Wellness: A Systematic Review, which is
currently being conducted by the AHRQ's Evidence-based Practice Centers
(EPC) Program. Access to published and unpublished pertinent scientific
information will improve the quality of this review.
DATES: Submission Deadline on or before January 21, 2025.
ADDRESSES:
Email submissions: [email protected].
Print submissions:
Mailing Address: Center for Evidence and Practice Improvement, Agency
for Healthcare Research and Quality, ATTN: EPC SEADs Coordinator, 5600
Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857
Shipping Address (FedEx, UPS, etc.): Center for Evidence and Practice
Improvement, Agency for Healthcare Research and Quality, ATTN: EPC
SEADs Coordinator, 5600 Fishers Lane, Mail Stop 06E77D, Rockville, MD
20857
FOR FURTHER INFORMATION CONTACT: Kelly Carper, eelephone: 301-427-1656
or email: [email protected].
SUPPLEMENTARY INFORMATION: The Agency for Healthcare Research and
Quality has commissioned the Evidence-based Practice Centers (EPC)
Program to complete a review of the evidence for Impact of Healthcare
Worker Safety and Wellness: A Systematic Review. AHRQ is conducting
this review pursuant to section 902 of the Public Health Service Act,
42 U.S.C. 299a.
The EPC Program is dedicated to identifying as many studies as
possible that are relevant to the questions for each of its reviews. In
order to do so, we are supplementing the usual manual and electronic
database searches of the
[[Page 103829]]
literature by requesting information from the public (e.g., details of
studies conducted). We are looking for studies that report on Impact of
Healthcare Worker Safety and Wellness: A Systematic Review. The entire
research protocol is available online at: https://effectivehealthcare.ahrq.gov/products/worker-safety-wellness/protocol.
This is to notify the public that the EPC Program would find the
following information on Impact of Healthcare Worker Safety and
Wellness: A Systematic Review helpful:
[ssquf] A list of completed studies that your organization has
sponsored for this topic. In the list, please indicate whether results
are available on ClinicalTrials.gov along with the ClinicalTrials.gov
trial number.
[ssquf] For completed studies that do not have results on
ClinicalTrials.gov, a summary, including the following elements, if
relevant: study number, study period, design, methodology, indication
and diagnosis, proper use instructions, inclusion and exclusion
criteria, primary and secondary outcomes, baseline characteristics,
number of patients screened/eligible/enrolled/lost to follow-up/
withdrawn/analyzed, effectiveness/efficacy, and safety results.
[ssquf] A list of ongoing studies that your organization has
sponsored for this topic. In the list, please provide the
ClinicalTrials.gov trial number or, if the trial is not registered, the
protocol for the study including, if relevant, a study number, the
study period, design, methodology, indication and diagnosis, proper use
instructions, inclusion and exclusion criteria, and primary and
secondary outcomes.
[ssquf] Description of whether the above studies constitute ALL
Phase II and above clinical trials sponsored by your organization for
this topic and an index outlining the relevant information in each
submitted file.
Your contribution is very beneficial to the Program. Materials
submitted must be publicly available or able to be made public.
Materials that are considered confidential; marketing materials; study
types not included in the review; or information on topics not included
in the review cannot be used by the EPC Program. This is a voluntary
request for information, and all costs for complying with this request
must be borne by the submitter.
The draft of this review will be posted on AHRQ's EPC Program
website and available for public comment for a period of 4 weeks. If
you would like to be notified when the draft is posted, please sign up
for the email list at: https://effectivehealthcare.ahrq.gov/email-updates.
The review will answer the following questions. This information is
provided as background. AHRQ is not requesting that the public provide
answers to these questions.
Contextual Question: What are the manifestations of impaired safety
and wellbeing of HCWs, such as burnout, moral injury, emotional
exhaustion, staff turnover, and physical injuries?
Key Questions (KQ)
KQ 1: What are the associations between healthcare delivery
conditions and HCW burnout?
KQ 2: What are the associations between HCW burnout and outcomes
for patients, HCW families, healthcare delivery organizations, and
society?
KQ 3: What are the effectiveness and harms of system-level
interventions targeting HCW burnout?
PECOTS (Populations, Exposures, Comparators, Outcomes, Timing and Setting) Eligibility Criteria for All Key Questions
--------------------------------------------------------------------------------------------------------------------------------------------------------
Element Key Question 1 Key Question 2 Key Question 3
--------------------------------------------------------------------------------------------------------------------------------------------------------
Population....................... HCWs at all organizational levels (e.g., those who provide direct patient care, support personnel, managers,
executives) Examples:
Physicians.
Nurses: registered nurses and advanced practice nurses.
Pharmacists.
Allied healthcare professionals (e.g., respiratory therapists, physical therapists, social workers,
emergency medical technicians).
Support personnel (e.g., environmental services).
Managers.
Executives.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Exposure......................... All healthcare delivery conditions HCW burnout, including instruments System-level programs: interventions
associated with the included studies such as: that intend to reduce or prevent HCW
will be recorded as exposures, Maslach Burnout Inventory burnout through the elimination or
including Oldenburg Burnout Inventory substitution of occupational
Societal conditions, Copenhagen Burnout Inventory hazards.
including federal and state laws like Two-Item Maslach Burnout Exclude: interventions that enable
nurse staffing laws, policies like Inventory the occupational hazard to remain in
pandemic restrictions and Physician Worklife Study place (engineering, administrative
credentialing, and unemployment, Single Item Question controls) or increase the individual
healthcare utilization, and ProQOL Burnout scale capacity to cope with the hazard
unionization rates. Institute for Professional (PPE, resilience training).
Organizational factors such Worklife Mini Z Survey
as payment model, level of care,
precarious and unstable scheduling,
safety culture.
Job and task-specific
factors, such as occupational class,
shift characteristics, working hours,
occupational stressors, support,
teamwork, and workplace hazards
Individual factors, such as age and
experience.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Comparator....................... Other healthcare delivery condition. Other levels of HCW burnout. Other intervention.
No intervention.
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 103830]]
Outcomes......................... HCW burnout, including instruments HCW family outcomes, such as: HCW burnout, including instruments
such as: [cir] Marital/relationship stress such as:
Maslach Burnout Inventory measured by a partner Maslach Burnout Inventory.
Oldenburg Burnout Inventory [cir] Divorce/separation rates Oldenburg Burnout Inventory.
Copenhagen Burnout Inventory Patient outcomes, such as: Copenhagen Burnout
Two-Item Maslach Burnout [cir] Safety Inventory.
Inventory [cir] Satisfaction Two-Item Maslach Burnout
Physician Worklife Study [cir] Adverse events Inventory.
Single Item Question [cir] Mortality Physician Worklife Study
Professional Quality of Life Healthcare organization Single Item Question.
(ProQOL) Burnout scale outcomes, such as: ProQOL Burnout scale.
Institute for Professional [cir] Productivity (including Institute for Professional
Worklife Mini Z Survey presenteeism, absenteeism, work- Worklife Mini Z Survey.
related injuries and illnesses)
[cir] Staff turnover (including due to
retirement, leaving the profession,
mortality, or suicide)
Societal outcomes, such as:
[cir] Workforce shortages
--------------------------------------------------------------------------------------------------------------------------------------------------------
Mediating Factors................ Individual factors such as stress, satisfaction, wellbeing, engagement, sleep quality, suicidal ideation,
depression, anxiety, meaningful work, mattering, moral distress or injury, workplace injury or illness.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Modifying Factors................ [cir] Demographic characteristics: (e.g., age, sex, race, ethnicity).
[cir] Occupational title (e.g., physician, nurse, allied health professional, other).
[cir] Educational attainment (e.g., high school, some college, college degree, graduate degree).
[cir] Experience (e.g., number of years employed).
[cir] Income (e.g., household income, socioeconomic status).
[cir] Time (e.g., year of outcome ascertainment, or binned by pre-, concurrent and post-pandemic).
[cir] Shift characteristics: (e.g., timing, duration, knowledge of shift, mandatory overtime).
[cir] Job tasks (e.g., patient-facing vs. non-patient-facing, physical demands as high, moderate, low).
[cir] Geographic location (e.g., U.S. census region, urban vs. suburban vs. rural).
--------------------------------------------------------------------------------------------------------------------------------------------------------
Study Designs.................... Cross-sectional studies. Randomized controlled
Cohort studies. trials.
Non-randomized controlled
trials.
Observational cohort studies
with a comparison group.
Pre-post studies (with
adjustment for confounders).
--------------------------------------------------------------------------------------------------------------------------------------------------------
Timing........................... Published since 2014.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Settings......................... All U.S. healthcare delivery settings where HCWs work (e.g., ambulatory, prehospital, emergency, various inpatient
services, post-acute or skilled nursing/long-term care, including medical, surgical, and mental health care
settings).
--------------------------------------------------------------------------------------------------------------------------------------------------------
Abbreviations: HCW = healthcare worker; PPE = personal protective equipment, ProQOL = Professional Quality of Life.
Dated: December 12, 2024.
Marquita Cullom,
Associate Director.
[FR Doc. 2024-30259 Filed 12-18-24; 8:45 am]
BILLING CODE 4160-90-P